ChemSpider 2D Image | L-Tyrosyl-L-prolyl-N-methyl-L-phenylalanyl-L-prolinamide | C29H37N5O5

L-Tyrosyl-L-prolyl-N-methyl-L-phenylalanyl-L-prolinamide

  • Molecular FormulaC29H37N5O5
  • Average mass535.635 Da
  • Monoisotopic mass535.279480 Da
  • ChemSpider ID8612597
  • defined stereocentres - 4 of 4 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

L-Prolinamide, L-tyrosyl-L-prolyl-N-methyl-L-phenylalanyl- [ACD/Index Name]
L-Tyrosyl-L-prolyl-N-methyl-L-phenylalanyl-L-prolinamid [German] [ACD/IUPAC Name]
L-Tyrosyl-L-prolyl-N-methyl-L-phenylalanyl-L-prolinamide [ACD/IUPAC Name]
L-Tyrosyl-L-prolyl-N-méthyl-L-phénylalanyl-L-prolinamide [French] [ACD/IUPAC Name]
[83397-56-2] [RN]
83397-56-2 [RN]
83435-59-0 [RN]
CHEMBL2371339
HU 310 | 2-Arachidonyl glycerol ether |
UN1170

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

CCRIS 4693 [DBID]
PL 017 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      7-TM Receptors Tocris Bioscience 2024
      Mu Opioid Receptors Tocris Bioscience 2024
      Opioid Receptors Tocris Bioscience 2024
      Selective ? agonist Tocris Bioscience 2024
      Selective ? opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to ? and ? sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo. Tocris Bioscience 2024
      Selective ? opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to ? and ? sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo. Tocris Bioscience 2024
      Selective mu agonist Tocris Bioscience 2024
      Selective mu opioid receptor agonist (IC50 values are 5.5 and > 10000 nM for inhibition of 125I-FK 33,824 and 125I-DADLE binding to mu and delta sites respectively). Produces naloxone-reversible analgesia, catalepsy and hyperthermia following central administration in rats in vivo. Tocris Bioscience 2024

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density: 1.3±0.1 g/cm3
Boiling Point: 878.5±65.0 °C at 760 mmHg
Vapour Pressure: 0.0±0.3 mmHg at 25°C
Enthalpy of Vaporization: 132.0±3.0 kJ/mol
Flash Point: 485.1±34.3 °C
Index of Refraction: 1.630
Molar Refractivity: 145.0±0.3 cm3
#H bond acceptors: 10
#H bond donors: 5
#Freely Rotating Bonds: 9
#Rule of 5 Violations: 3
ACD/LogP: 0.93
ACD/LogD (pH 5.5): -1.04
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 1.00
ACD/LogD (pH 7.4): 0.65
ACD/BCF (pH 7.4): 1.15
ACD/KOC (pH 7.4): 22.13
Polar Surface Area: 150 Å2
Polarizability: 57.5±0.5 10-24cm3
Surface Tension: 66.9±3.0 dyne/cm
Molar Volume: 407.7±3.0 cm3

Click to predict properties on the Chemicalize site






Advertisement